Investing
EU antitrust regulators set Oct. 19 deadline for Pfizer’s Seagen deal
© Reuters. Test tubes are seen in front of Seagen logo in this illustration taken June 27, 2022. REUTERS/Dado Ruvic/Illustration/File Photo
BRUSSELS (Reuters) – Pfizer (NYSE:)’s $43 billion bid for Seagen will be decided by EU antitrust regulators by Oct. 19, a regulatory filing showed on Friday.
U.S. pharmaceutical company Pfizer announced the deal, its biggest, in March for Washington-based Seagen, a pioneer of antibody-drug conjugates, which work like “guided missiles” designed to destroy cancer while sparing healthy cells.
The European Commission can either clear the deal after a preliminary review or it can start a four-month long investigation if it has serious concerns.
Pfizer sought EU antitrust approval on Thursday.
Read the full article here
-
Side Hustles6 days ago
Mark Zuckerberg Is Now Second Richest Person in the World
-
Investing6 days ago
Nvidia CEO Jensen Huang: Demand For Blackwell AI Is Insane
-
Side Hustles6 days ago
Meta Previews Movie Gen, AI Tools That Turn Dreams to Videos
-
Investing4 days ago
Hurricane Helene Hits Spruce Pine Mine, Quartz Used for Tech
-
Investing5 days ago
Israel stocks lower at close of trade; TA 35 down 0.23% By Investing.com
-
Side Hustles5 days ago
5 Key Strategies for a Seamless Cloud Migration
-
Investing6 days ago
BCA says investors should fade the real estate rally By Investing.com
-
Passive Income5 days ago
Go Paperless with the PDF Reader Pro for $49.99